Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 0 Clinical Protocol: A Longitudinal and Multimodal Exploratory Study to Evaluate a Neuroinflammatory Hypothesis in Patients With Schizophrenia Compared to Young Healthy Subjects

NCT02009826 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT02009826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02009826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 0 Clinical Protocol: A Longitudinal and Multimodal Exploratory Study to Evaluate a Neuroinflammatory Hypothesis in Patients With Schizophrenia Compared to Young Healthy Subjects
Lead sponsor
Universiteit Antwerpen
Phase
Observational
Overall status
Completed
Start date
November 30, 2013
Completion date
February 28, 2017
Enrollment
106 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis, schizophrenia